RENOVA BIOMED

What RENOVA BIOMED does

Renova Biomed is an Italian medical device manufacturer headquartered in Rome, Italy. Founded in 2000, the company produces products spanning three clinical categories: pain therapy, plastic surgery, and regenerative medicine. The firm operates as a private, for-profit entity with no public IPO or funding history reflected in the available sources. Its functional orientation — manufacturing devices and consumables for specialty clinical use rather than consumer products — implies distribution through medical channels (hospitals, specialty clinics, plastic surgeons, pain management physicians) under appropriate medical-device regulatory regimes (e.g., EU MDR/IVDR, CE marking, ISO 13485 quality system), though no specific clearances are enumerated in the available data.

The current publicly accessible website returns only a security verification/loader screen and provides no product catalog, no leadership disclosure, no pricing, no certification list, no partnership disclosures, and no investor information. The input aggregation therefore supports only the most basic firmographic profile: a long-tenured (25 years) Italian medical device company with a narrow but clinically diversified product focus in pain management, aesthetic/reconstructive surgery, and regenerative medicine. No information is available on manufacturing footprint, R&D pipeline, distribution partners, geographic markets served, or technology stack.

The business model cannot be precisely characterized from the data provided. There is no pricing detail, no GTM motion documented, no customer logos, no segment mix, no headcount, and no revenue figures. For investment-analytic purposes, Renova Biomed is best characterized as a data-thin, privately held, niche European medical device manufacturer whose category reach (pain, plastic surgery, regenerative medicine) is suggestive of specialty-clinic distribution but whose actual scale, economics, and strategic direction require primary-source diligence before any conclusion can be drawn.

Name

RENOVA BIOMED

Website

https://renovabiomed.it

Company type

Private

Founded year

2000

Headcount range

1–10 employees

Short description

Renova Biomed is a privately held Italian medical device manufacturer, founded in 2000 and headquartered in Rome, that produces products for pain therapy, plastic surgery, and regenerative medicine for clinical specialty customers.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Biological Product (except Diagnostic) Manufacturing (325414), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE)

akta.pro secondary industries

Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH), Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)

Keywords

• Medical device manufacturing
• Pain therapy products
• Plastic surgery supplies
• Regenerative medicine
• Medical product manufacturer

Headquarters

HQ city

Rome

HQ country

Italy

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Core offering

Renova Biomed is a manufacturer of medical products serving three therapeutic segments: pain therapy, plastic surgery, and regenerative medicine. The company produces physical medical devices and supplies used by healthcare professionals and medical facilities in patient treatment and surgical procedures.

Product overview

No product information available from source data. The source website (http://renovabiomed.it/) returned only a loading/verification page stating 'One moment, please...' with no substantive company, product, or service content.

Differentiator

Problem solved

Functional benefit

Products and services

• Pain therapy medical products Medical products manufactured for pain therapy applications, intended for healthcare providers treating patients with pain conditions.
• Plastic surgery medical products Medical products manufactured for plastic surgery procedures, supplied to plastic surgeons and surgical facilities.
• Regenerative medicine medical products Medical products manufactured for regenerative medicine applications, supporting biological healing and tissue repair treatments.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Organogenesis: Commercializes regenerative medicine products including skin substitutes and wound care biologics used in plastic surgery and chronic wound management. Direct overlap with RENOVA BIOMED's plastic surgery and regenerative medicine verticals.
• MiMedx: Specializes in regenerative medicine products derived from placental tissue for wound healing, surgical recovery, and pain management. Closely aligned with RENOVA BIOMED's regenerative medicine and pain therapy focus.
• Vericel: Develops and commercializes advanced cell therapies and regenerative medicine products for cartilage repair and burns/wounds, directly mirroring RENOVA BIOMED's regenerative and plastic surgery positioning.
• RTI Surgical: Manufactures regenerative surgical implants including biologic scaffolds for orthopedic, spine, and sports medicine - overlapping with pain therapy and regenerative medicine applications.

Broad incumbents

• Stryker: Large diversified medical device firm with orthopedic, pain management, and surgical equipment franchises - a broad incumbent overlapping in pain therapy devices and regenerative surgical products.
• Smith & Nephew: Global medical device manufacturer with significant wound management, regenerative medicine, and orthopedic/pain therapy franchises. Directly comparable as a multi-vertical regenerative and surgical products manufacturer serving hospitals and clinics.
• Integra LifeSciences: Broad medical technology company with regenerative tissue technologies (DuraGen, Integra Dermal Regeneration Template) used in plastic/reconstructive surgery and wound care. Comparable in regenerative and surgical appliance manufacturing.

Emerging players

• Collagen Solutions: Supplies medical-grade collagen and biomaterials used in regenerative medicine, wound healing, and tissue engineering applications - adjacent supplier-level peer in the regenerative biologics value chain.
• MediWound: Specialty biologics company focused on enzymatic wound debridement and regenerative skin therapies for burn and chronic wound care - relevant peer in plastic surgery/reconstructive regenerative wound products.

Regional players

• Finceramica: Italian medical device company developing regenerative bone and cartilage substitutes and tissue engineering products - comparable European/Italian peer in regenerative medicine manufacturing.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat1 record

Key risks5 records

Key highlights4 records

Customer concentration

• Facebookfacebook.com/renovabiomed
• LinkedInlinkedin.com/company/renova-biomed

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RENOVA BIOMED